Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Renal Failure
  Free Subscription

Articles published in
Kidney Int
    April 2024
  1. WONG G, Bernier-Jean A, Rovin B, Ronco P, et al
    Time for Action: Recognising chronic kidney disease as a major non-communicable disease driver of premature mortality.
    Kidney Int. 2024 Apr 2:S0085-2538(24)00247-3. doi: 10.1016/j.kint.2024.
    >> Share


  2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
    Kidney Int. 2024;105.
    >> Share

  3. LEVIN A, Ahmed SB, Carrero JJ, Foster B, et al
    Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
    Kidney Int. 2024;105:684-701.
    >> Share

    March 2024
  4. WINKELMAYER WC, Lensing AWA, Thadhani RI, Mahaffey KW, et al
    A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis.
    Kidney Int. 2024 Mar 25:S0085-2538(24)00196-0. doi: 10.1016/j.kint.2024.
    >> Share

  5. PIETERS TT, Besseling PJ, Bovee DM, Rookmaaker MB, et al
    Discrepancies between transcutaneous and estimated glomerular filtration rates in rats with chronic kidney disease.
    Kidney Int. 2024 Mar 19:S0085-2538(24)00187-X. doi: 10.1016/j.kint.2024.
    >> Share

  6. GILL JS, Chadban SJ
    Pretransplant screening for coronary artery disease: data are required before practice change.
    Kidney Int. 2024;105:470-472.
    >> Share

    February 2024
  7. LEE J, Lee J, Kim K, Lee J, et al
    Antibiotic-induced intestinal microbiota depletion can attenuate the acute kidney injury to chronic kidney disease transition via NADPH oxidase 2 and trimethylamine-N-oxide inhibition.
    Kidney Int. 2024 Feb 29:S0085-2538(24)00163-7. doi: 10.1016/j.kint.2024.
    >> Share

  8. OLIVEIRA EA, Simoes E Silva AC, Colosimo EA
    Predictive models of chronic kidney disease progression in pediatric patients.
    Kidney Int. 2024;105:393.
    >> Share

    January 2024
  9. REZNICHENKO A, Nair V, Eddy S, Fermin D, et al
    Unbiased kidney-centric molecular categorization of chronic kidney disease as a step towards precision medicine.
    Kidney Int. 2024 Jan 27:S0085-2538(24)00068-1. doi: 10.1016/j.kint.2024.
    >> Share

  10. KAARTINEN K, Schenk P, Raisanen-Sokolowski A, Dunkel J, et al
    The Case | Refractory anemia in a patient undergoing dialysis.
    Kidney Int. 2024;105:211-212.
    >> Share

  11. LARKWORTHY J, Ghalli F, Mortensen C
    Asymptomatic migration of a peritoneal dialysis catheter.
    Kidney Int. 2024;105:209.
    >> Share

    December 2023
  12. PARK CH, Kim HW, Joo YS, Park JT, et al
    Findings from the KNOW-CKD Study indicates that higher systolic blood pressure time in target range is associated with a lower risk of chronic kidney disease progression.
    Kidney Int. 2023 Dec 28:S0085-2538(23)00918-3. doi: 10.1016/j.kint.2023.
    >> Share

  13. LI X, Bhattacharya D, Yuan Y, Wei C, et al
    Chronic kidney disease in a murine model of non-alcoholic steatohepatitis (NASH).
    Kidney Int. 2023 Dec 28:S0085-2538(23)00919-5. doi: 10.1016/j.kint.2023.
    >> Share

  14. FU EL, Mastrorilli J, Bykov K, Wexler DJ, et al
    A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes.
    Kidney Int. 2023 Dec 13:S0085-2538(23)00865-7. doi: 10.1016/j.kint.2023.
    >> Share

  15. SANTORIELLO D, Schilling K, Glabonjat RA, Charlesworth JE, et al
    The Case | Chronic kidney disease associated with nuclear inclusion bodies in proximal tubular cells.
    Kidney Int. 2023;104:1231-1232.
    >> Share

    November 2023
  16. BEAMISH JA, Telang AC, McElliott MC, Al-Suraimi A, et al
    Pax protein depletion in proximal tubules triggers conserved mechanisms of resistance to acute ischemic kidney injury preventing transition to chronic kidney disease.
    Kidney Int. 2023 Nov 15:S0085-2538(23)00774-3. doi: 10.1016/j.kint.2023.
    >> Share

  17. TABER-HIGHT E, Gilmore A, Friedman AN
    Antiobesity Pharmacotherapy in Adults with Chronic Kidney Disease.
    Kidney Int. 2023 Nov 3:S0085-2538(23)00762-7. doi: 10.1016/j.kint.2023.
    >> Share

  18. DRUEKE TB, Ikizler TA
    Is hemodiafiltration superior to hemodialysis in patients with kidney failure?
    Kidney Int. 2023;104:874-877.
    >> Share

    October 2023
  19. CAVALIER E, Farre-Segura J, Lukas P, Gendebien AS, et al
    Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease.
    Kidney Int. 2023 Oct 31:S0085-2538(23)00761-5. doi: 10.1016/j.kint.2023.
    >> Share

  20. BATEMAN S, Riceman M, Owen K, Pearson O, et al
    Models of care to address disparities in kidney health outcomes for First Nations people.
    Kidney Int. 2023;104:681-689.
    >> Share

    September 2023
  21. BHANDARI S, Mehta S, Khawaja A, Cleland JGF, et al
    Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease.
    Kidney Int. 2023 Sep 30:S0085-2538(23)00676-2. doi: 10.1016/j.kint.2023.
    >> Share

  22. WANG Y, Ran L, Lan Q, Liao W, et al
    Imbalanced lipid homeostasis caused by membrane alphaKlotho deficiency contributes to the acute kidney injury to chronic kidney disease transition.
    Kidney Int. 2023 Sep 4:S0085-2538(23)00614-2. doi: 10.1016/j.kint.2023.
    >> Share

  23. EL SHAMY O, Ikizler TA
    Fluid management protocols in hemodialysis patients using bioimpedance validation: time to look elsewhere?
    Kidney Int. 2023;104:425-427.
    >> Share

    August 2023
  24. CHAN KW, Smeijer JD, Schechter M, Jongs N, et al
    Post-hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney disease.
    Kidney Int. 2023 Aug 30:S0085-2538(23)00610-5. doi: 10.1016/j.kint.2023.
    >> Share

  25. ALBRECHT LV, Pereira RC, Salusky IB
    All the Might of the Osteocyte: Emerging Roles in Chronic Kidney Disease.
    Kidney Int. 2023 Aug 28:S0085-2538(23)00603-8. doi: 10.1016/j.kint.2023.
    >> Share

  26. VERVLOET MG, Hsu S, de Boer IH
    Vitamin D supplementation in people with chronic kidney disease.
    Kidney Int. 2023 Aug 2:S0085-2538(23)00540-9. doi: 10.1016/j.kint.2023.
    >> Share

  27. PETZOLD F, Billot K, Chen X, Henry C, et al
    The genetic landscape and clinical spectrum of nephronophthisis and related ciliopathies.
    Kidney Int. 2023;104:378-387.
    >> Share

    July 2023
  28. HONG S, Kim KS, Han K, Park CY, et al
    A cohort study found a high risk of end-stage kidney disease associated with acromegaly.
    Kidney Int. 2023 Jul 23:S0085-2538(23)00501-X. doi: 10.1016/j.kint.2023.
    >> Share

    June 2023
  29. NG DK, Matheson MB, Schwartz GJ, Wang FM, et al
    Development of an adaptive clinical web-based prediction tool for kidney replacement therapy in children with chronic kidney disease.
    Kidney Int. 2023 Jun 28:S0085-2538(23)00474-X. doi: 10.1016/j.kint.2023.
    >> Share

  30. FAUCON AL, Fu EL, Stengel B, Mazhar F, et al
    A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality.
    Kidney Int. 2023 Jun 15:S0085-2538(23)00418-0. doi: 10.1016/j.kint.2023.
    >> Share

  31. MEHROTRA R, Davison SN, Farrington K, Flythe JE, et al
    Managing the Symptom Burden Associated with Maintenance Dialysis: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2023 Jun 6:S0085-2538(23)00399-X. doi: 10.1016/j.kint.2023.
    >> Share

    May 2023
  32. DAVIES SJ, Coyle D, Lindley EJ, Keane D, et al
    Bio-impedance spectroscopy added to a fluid management protocol does not improve preservation of residual kidney function in incident hemodialysis patients in a randomized controlled trial.
    Kidney Int. 2023 May 30:S0085-2538(23)00394-0. doi: 10.1016/j.kint.2023.
    >> Share

  33. ECKARDT KU, Delgado C, Heerspink HJL, Pecoits-Filho R, et al
    Trends and Perspectives for Improving Quality of Chronic Kidney Disease Care: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2023 May 26:S0085-2538(23)00388-5. doi: 10.1016/j.kint.2023.
    >> Share

  34. KU E, Del Vecchio L, Eckardt KU, Haase VH, et al
    Novel Anemia Therapies in CKD: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2023 May 24:S0085-2538(23)00379-4. doi: 10.1016/j.kint.2023.
    >> Share

  35. ALASFAR S, Alashavi H, Nasan KH, Haj Mousa AA, et al
    Improving and maintaining quality of hemodialysis in areas affected by war: a call to action!
    Kidney Int. 2023;103:817-820.
    >> Share

    April 2023
  36. SIECKMANN T, Schley G, Ogel N, Kelterborn S, et al
    Strikingly conserved gene expression changes of polyamine regulating enzymes among various forms of acute and chronic kidney injury.
    Kidney Int. 2023 Apr 28:S0085-2538(23)00310-1. doi: 10.1016/j.kint.2023.
    >> Share

  37. HMIDA MB, Mechichi T, Piccoli GB, Ksibi M, et al
    Water implications in Dialysis Therapy, Threats and Opportunities to Reduce Water Consumption: A Call for the Planet.
    Kidney Int. 2023 Apr 26:S0085-2538(23)00314-9. doi: 10.1016/j.kint.2023.
    >> Share

  38. LEVIN A, Okpechi IG, Caskey FJ, Yang CW, et al
    Perspectives on early detection of chronic kidney disease: the facts, the questions, and a proposed framework for 2023 and beyond.
    Kidney Int. 2023 Apr 18:S0085-2538(23)00176-X. doi: 10.1016/j.kint.2023.
    >> Share

  39. MAVRAKANAS TA
    Apixaban for stroke prevention in hemodialysis patients with nonvalvular atrial fibrillation.
    Kidney Int. 2023 Apr 12:S0085-2538(23)00252-1. doi: 10.1016/j.kint.2023.
    >> Share

  40. O'LONE E, Apple FS, Burton JO, Caskey FJ, et al
    Defining Myocardial Infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group.
    Kidney Int. 2023 Apr 4:S0085-2538(23)00228-4. doi: 10.1016/j.kint.2023.
    >> Share

  41. BASU S, Dorling A, Chong AS
    A transitional B-cell cytokine biomarker for risk stratifying renal transplant patients with borderline rejection.
    Kidney Int. 2023;103:658-660.
    >> Share

    March 2023
  42. BAKSHI A, Jefferis J, Wolfe R, Wetmore JB, et al
    Association of polygenic scores with chronic kidney disease phenotypes in a longitudinal study of older adults.
    Kidney Int. 2023 Mar 29:S0085-2538(23)00184-9. doi: 10.1016/j.kint.2023.
    >> Share

  43. DOLMATCH B, Cabrera T, Pergola P, Balamuthusamy S, et al
    Prospective, Randomized, Multicenter, Clinical Study Comparing a Self-Expanding Covered Stent to Percutaneous Transluminal Angioplasty for Treatment of Upper Extremity Hemodialysis Arteriovenous Fistula Stenosis.
    Kidney Int. 2023 Mar 27:S0085-2538(23)00182-5. doi: 10.1016/j.kint.2023.
    >> Share

  44. RANCHIN B, Schmitt CP, Warady B, Craig JC, et al
    Devices for long-term hemodialysis in small children - a plea for action.
    Kidney Int. 2023 Mar 27:S0085-2538(23)00185-0. doi: 10.1016/j.kint.2023.
    >> Share

  45. OLIVARI V, Di Modica SM, Lidonnici MR, Aghajan M, et al
    A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
    Kidney Int. 2023 Mar 27:S0085-2538(23)00179-5. doi: 10.1016/j.kint.2023.
    >> Share

  46. JOHANSEN KL, Cobitz AR, Singh AK, Macdougall IC, et al
    The ASCEND-NHQ trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis-dependent chronic kidney disease.
    Kidney Int. 2023 Mar 1:S0085-2538(23)00143-6. doi: 10.1016/j.kint.2023.
    >> Share

    February 2023
  47. QIN S, Liu C, Chen Y, Yao M, et al
    Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy.
    Kidney Int. 2023 Feb 17:S0085-2538(23)00086-8. doi: 10.1016/j.kint.2023.
    >> Share

  48. IMAIZUMI T, Fujii N, Hamano T, Yang W, et al
    Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function.
    Kidney Int. 2023 Feb 2:S0085-2538(23)00055-8. doi: 10.1016/j.kint.2023.
    >> Share

  49. ROSHANOV PS, Garg AX
    TIPS to decide whether to prescribe aspirin for the primary prevention of cardiovascular events in chronic kidney disease.
    Kidney Int. 2023;103:261-263.
    >> Share

  50. JOHNSON RJ, Warady BA
    Does kidney transplant improve health-related quality of life for youth with chronic kidney disease?
    Kidney Int. 2023;103:256-258.
    >> Share

    January 2023
  51. PERL J, Brown EA, Chan CT, Couchoud C, et al
    Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2023 Jan 30:S0085-2538(23)00051-0. doi: 10.1016/j.kint.2023.
    >> Share

  52. NAYLOR KL, McArthur E, Dixon SN, Kwong JC, et al
    Impact of study design on vaccine effectiveness estimates of two mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease.
    Kidney Int. 2023 Jan 30:S0085-2538(23)00057-1. doi: 10.1016/j.kint.2023.
    >> Share

  53. CHANG CJ, Lai YJ, Tung YC, Wu LS, et al
    Osteopontin mediation of disturbed flow-induced endothelial mesenchymal transition through CD44 is a novel mechanism of neointimal hyperplasia in arteriovenous fistulae for hemodialysis access.
    Kidney Int. 2023 Jan 13:S0085-2538(23)00011-X. doi: 10.1016/j.kint.2022.
    >> Share

  54. TANIGUCHI T, Tomita M, Iehara N
    The Case | Hyperammonemia in a non-cirrhotic hemodialysis patient.
    Kidney Int. 2023;103:233-234.
    >> Share

  55. HECKING M, Madero M, Port FK, Schneditz D, et al
    Fluid volume management in hemodialysis: never give up!
    Kidney Int. 2023;103:2-5.
    >> Share

  56. SMYTH B, Glaser J, Butler-Dawson J, Nanayakkara N, et al
    Challenges and opportunities in interventions for chronic kidney disease of unknown origin (CKDu): report from the International Society of Nephrology Consortium of Collaborators on CKDu.
    Kidney Int. 2023;103:6-12.
    >> Share

  57. FU EL, Kutz A, Desai RJ
    Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown.
    Kidney Int. 2023;103:30-33.
    >> Share

    December 2022
  58. STEINBRENNER I, Yu Z, Jin J, Schultheiss UT, et al
    A Polygenic Score for Reduced Kidney Function and Adverse Outcomes in a Chronic Kidney Disease Cohort.
    Kidney Int. 2022 Dec 5:S0085-2538(22)00973-5. doi: 10.1016/j.kint.2022.
    >> Share

  59. MARTIN P, Awan AA, Berenguer MC, Bruchfeld A, et al
    Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.
    Kidney Int. 2022;102:1228-1237.
    >> Share

  60. DRUEKE TB, Massy ZA
    Vascular calcification in chronic kidney disease: contribution of ferroptosis?
    Kidney Int. 2022;102:1209-1211.
    >> Share


  61. KDIGO 2022 Clinical Practice Guideline FOR the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.
    Kidney Int. 2022;102.
    >> Share

    November 2022
  62. MAZHAR F, Sjolander A, Fu EL, Arnlov J, et al
    Estimating the prevalence of chronic kidney disease while accounting for non-random testing with inverse probability weighting.
    Kidney Int. 2022 Nov 30:S0085-2538(22)00971-1. doi: 10.1016/j.kint.2022.
    >> Share

  63. CHERUKURI A, Abou-Daya KI, Chowdhury R, Mehta RB, et al
    Transitional B cell Cytokines Risk Stratify Early Borderline Rejection After Renal Transplantation.
    Kidney Int. 2022 Nov 24:S0085-2538(22)00969-3. doi: 10.1016/j.kint.2022.
    >> Share


  64. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.
    Kidney Int. 2022;102.
    >> Share

  65. ROSSING P, Caramori ML, Chan JCN, Heerspink HJL, et al
    Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence.
    Kidney Int. 2022;102:990-999.
    >> Share

  66. DE CHIARA L, Romagnani P
    Polyploid tubular cells and chronic kidney disease.
    Kidney Int. 2022;102:959-961.
    >> Share

    October 2022
  67. GUHA C, van Zwieten A, Khalid R, Kim S, et al
    Longitudinal assessment of the health-related quality of life of children and adolescents with chronic kidney disease.
    Kidney Int. 2022 Oct 28. pii: S0085-2538(22)00906.
    >> Share

  68. BAKRIS GL, Ruilope LM, Anker SD, Filippatos G, et al
    Analysis from the FIDELITY study examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes.
    Kidney Int. 2022 Oct 28. pii: S0085-2538(22)00910.
    >> Share

  69. MANN JFE, Joseph P, Gao P, Pais P, et al
    Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease.
    Kidney Int. 2022 Oct 27. pii: S0085-2538(22)00848.
    >> Share

  70. BERNIER-JEAN A, Drueke TB
    Potassium intake in patients with chronic kidney disease.
    Kidney Int. 2022;102:706-707.
    >> Share

  71. ELSURER AFSAR R, Ikizler TA
    Dietary sodium restriction in heart failure and chronic kidney disease: more evidence emerges.
    Kidney Int. 2022;102:680-682.
    >> Share

    September 2022
  72. DE BOER IH, Khunti K, Sadusky T, Tuttle KR, et al
    Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).
    Kidney Int. 2022 Sep 27. pii: S0085-2538(22)00634.
    >> Share

  73. ATIQUZZAMAN M, Zheng Y, Er L, Djurdjev O, et al
    COVID-19 vaccine effectiveness in patients with non-dialysis dependent chronic kidney diseases; findings from a population based observational study from British Columbia, Canada.
    Kidney Int. 2022 Sep 11. pii: S0085-2538(22)00719.
    >> Share

  74. GIARRATANO Y, Pugh D, Farrah TE, Oniscu GC, et al
    Novel retinal vascular phenotypes for the potential assessment of long-term risk in living kidney donors.
    Kidney Int. 2022;102:661-665.
    >> Share

    August 2022
  75. TAK CHENG FW, Fan M, Ho Wong CK, Ling Chui CS, et al
    The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases.
    Kidney Int. 2022 Aug 11. pii: S0085-2538(22)00610.
    >> Share

  76. AIRIK M, Phua YL, Huynh AB, McCourt BT, et al
    Persistent DNA damage underlies tubular cell polyploidization and progression to chronic kidney disease in kidneys deficient in the DNA repair protein FAN1.
    Kidney Int. 2022 Aug 2. pii: S0085-2538(22)00545.
    >> Share

    July 2022
  77. KOPPE L, Soulage CO
    The impact of dietary nutrient intake on gut microbiota in the progression and complications of chronic kidney disease.
    Kidney Int. 2022 Jul 20. pii: S0085-2538(22)00538.
    >> Share

  78. DEMBER LM, Hung A, Mehrotra R, Hsu JY, et al
    A randomized controlled pilot trial of anakinra for hemodialysis inflammation.
    Kidney Int. 2022 Jul 19. pii: S0085-2538(22)00535.
    >> Share

  79. ZENG W, Beyene HB, Kuokkanen M, Miao G, et al
    Lipidomic profiling in the Strong Heart Study identified American Indians at risk of chronic kidney disease.
    Kidney Int. 2022 Jul 16. pii: S0085-2538(22)00536.
    >> Share

  80. MAJOR RW, Cockwell P, Nitsch D, Tangri N, et al
    The next step in chronic kidney disease staging: individualized risk prediction.
    Kidney Int. 2022 Jul 13. pii: S0085-2538(22)00517.
    >> Share

  81. TORREGGIANI M, Fois A, Fessi H, Piccoli GB, et al
    Are randomized trials the best way to test different dialysis initiation regimens?
    Kidney Int. 2022;102:208-209.
    >> Share

  82. FLOEGE J, Wied S, Rauen T
    Assessing prognosis in IgA nephropathy.
    Kidney Int. 2022;102:22-24.
    >> Share

  83. KERR M, Evangelidis N, Abbott P, Craig JC, et al
    Indigenous peoples' perspectives of living with chronic kidney disease: systematic review of qualitative studies.
    Kidney Int. 2022 Jul 1. pii: S0085-2538(22)00508.
    >> Share

    June 2022
  84. ASSIMON MM, Pun PH, Wang L, Al-Khatib SM, et al
    Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure.
    Kidney Int. 2022 Jun 22. pii: S0085-2538(22)00461.
    >> Share

  85. DASHTBAN A, Mizani MA, Denaxas S, Nitsch D, et al
    A retrospective cohort study measured predicting and validating the impact of the COVID-19 pandemic in individuals with chronic kidney disease.
    Kidney Int. 2022 Jun 15. pii: S0085-2538(22)00448.
    >> Share

  86. SUBBIAH A, Bhowmik D
    KDIGO recommendations on blood pressure management in chronic kidney disease.
    Kidney Int. 2022;101:1299.
    >> Share

    May 2022
  87. SHROFF R, Lalayiannis AD, Fewtrell M, Schmitt CP, et al
    Naturally occurring stable calcium isotope ratios are a novel biomarker of bone calcium balance in chronic kidney disease.
    Kidney Int. 2022 May 26. pii: S0085-2538(22)00374.
    >> Share

  88. ANFT M, Blazquez-Navarro A, Frahnert M, Fricke L, et al
    Inferior cellular and humoral immunity against Omicron and Delta VOC compared to SARS-CoV-2 wild-type in hemodialysis patients immunized with four SARS-CoV-2 vaccine doses.
    Kidney Int. 2022 May 14. pii: S0085-2538(22)00367.
    >> Share

  89. YANUCIL C, Kentrup D, Campos I, Czaya B, et al
    Soluble alpha-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease.
    Kidney Int. 2022 May 2. pii: S0085-2538(22)00347.
    >> Share

  90. COATES PT, Wong G, Rovin BH, Ronco P, et al
    A challenge to the kidney community by a man-made crisis.
    Kidney Int. 2022;101:854-855.
    >> Share

  91. ZHANG MQ, Jia XY, Yang ZK, Ma TT, et al
    Pouch of Douglas hernia in a patient on peritoneal dialysis.
    Kidney Int. 2022;101:1090.
    >> Share

  92. YANG C, Zhang X, Xie X, Zhao Y, et al
    Comments on "Ultrasound findings of calciphylaxis".
    Kidney Int. 2022;101:1085.
    >> Share

  93. IVERSEN E, Bengaard AK, Andersen A, Kallemose T, et al
    Performance of the Cockcroft-Gault, Modification of Diet in Renal Disease, and new Chronic Kidney Disease Epidemiology Collaboration equations without race in older acute medical patients.
    Kidney Int. 2022;101:1087-1088.
    >> Share

  94. INOUE T, Kozawa E, Ishikawa M, Kobayashi N, et al
    The relationship between imaging features of diffusion-weighted imaging and prognosis of chronic kidney disease.
    Kidney Int. 2022;101:1083.
    >> Share

    April 2022

  95. Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2022 Apr 20. pii: S0085-2538(22)00278.
    >> Share

  96. HOUSSET P, Kubab S, Hanafi L, Pardon A, et al
    Humoral response after a fourth "booster" dose of a Covid-19 vaccine following a 3-dose regimen of mRNA-based vaccination in dialysis patients.
    Kidney Int. 2022 Apr 11. pii: S0085-2538(22)00282.
    >> Share

  97. AL-WAHSH H, Lam NN, Quinn RR, Ronksley PE, et al
    Calculated versus measured albumin-creatinine ratio to predict kidney failure and death in people with chronic kidney disease.
    Kidney Int. 2022 Apr 7. pii: S0085-2538(22)00268.
    >> Share

  98. LOGEL SN, Connor EL, Paloian NJ
    The Case | A 17-year-old boy with growth failure and chronic kidney disease.
    Kidney Int. 2022;101:837-838.
    >> Share

    March 2022
  99. CINKILIC O, Anft M, Blazquez-Navarro A, Meister TL, et al
    Inferior humoral and sustained cellular immunity against wild type and omicron VOC in hemodialysis patients immunized with three SARS-CoV-2 vaccine doses compared to four doses.
    Kidney Int. 2022 Mar 14. pii: S0085-2538(22)00204.
    >> Share

  100. CORREMANS R, Neven E, Maudsley S, Leysen H, et al
    Progression of established non-diabetic chronic kidney disease is halted by metformin treatment in rats.
    Kidney Int. 2022 Mar 7. pii: S0085-2538(22)00176.
    >> Share

  101. LAMY G, Kahn JE, Huscenot T, Dargelos M, et al
    The Case | Hypereosinophilia in a hemodialysis patient.
    Kidney Int. 2022;101:657-658.
    >> Share

  102. IKIZLER TA
    Initiation of maintenance dialysis: back to the future.
    Kidney Int. 2022;101:471-472.
    >> Share

  103. WANNER C, Lopau K, Haberstroh H
    The safety and feasibility of incremental dialysis must be proven before its widespread use.
    Kidney Int. 2022;101:468-471.
    >> Share

  104. LINDLEY E, Tattersall J
    Don't deny it! Incremental dialysis is compassionate, logical, and patient-centered.
    Kidney Int. 2022;101:465-468.
    >> Share

  105. JOLES JA
    Anemia and red blood cell deformability in proteinuric chronic kidney disease.
    Kidney Int. 2022;101:649.
    >> Share

  106. MCKAY AM, Teoh CW
    Sex differences in cardiovascular disease burden in children with chronic kidney disease.
    Kidney Int. 2022;101:462-464.
    >> Share

  107. MASSY ZA, Liabeuf S
    Sortilin, carbamylation, and cardiovascular calcification in chronic kidney disease.
    Kidney Int. 2022;101:456-459.
    >> Share

    February 2022
  108. USUI N, Nakata J, Uehata A, Ando S, et al
    Association of cardiac autonomic neuropathy assessed by heart rate response during exercise with intradialytic hypotension and mortality in hemodialysis patients.
    Kidney Int. 2022 Feb 25. pii: S0085-2538(22)00162.
    >> Share

  109. BEVILACQUA M, Induruwage D, Williams J, Djurdjev O, et al
    Adverse changes in key chronic kidney disease care outcome metrics since onset of the COVID-19 pandemic; experience from an established provincial renal program.
    Kidney Int. 2022 Feb 21. pii: S0085-2538(22)00111.
    >> Share

  110. EL KAROUI K, De Vriese AS
    COVID-19 in dialysis: clinical impact, immune response, prevention and treatment.
    Kidney Int. 2022 Feb 14. pii: S0085-2538(22)00099.
    >> Share

  111. LEES JS, Mark PB
    Insights into vitamin K metabolism in chronic kidney disease: more complicated than kale deficiency.
    Kidney Int. 2022;101:216-219.
    >> Share

  112. RHEE EP, Surapaneni A, Zheng Z, Zhou L, et al
    Trans-ethnic genome-wide association study of blood metabolites in the chronic renal insufficiency cohort (CRIC) study.
    Kidney Int. 2022 Feb 1. pii: S0085-2538(22)00083.
    >> Share

    January 2022
  113. BERCHTOLD L, Crowe LA, Combescure C, Kassai M, et al
    Diffusion-Magnetic Resonance Imaging predicts decline of kidney function in chronic kidney disease and in patients with a kidney allograft.
    Kidney Int. 2022 Jan 11. pii: S0085-2538(21)01215.
    >> Share

  114. EL SHAMY O, Ikizler TA
    Aquaporin-1 Variants: A step further towards precise prescription in Peritoneal Dialysis?
    Kidney Int. 2022 Jan 4. pii: S0085-2538(21)01224.
    >> Share

  115. RODRIGUEZ-ESPINOSA D, Broseta JJ, Garrote M, Quintana LF, et al
    The Case | Persistent fever in a hemodialysis patient.
    Kidney Int. 2022;101:193-194.
    >> Share

  116. ZACHARIAH VK, Gandhi SB, Sunitha VC, Priyamvada PS, et al
    Windswept deformity of lower limbs in a patient with end-stage renal disease and rickets.
    Kidney Int. 2022;101:190.
    >> Share

  117. HASEGAWA S, Nangaku M
    SGLT2 inhibition in chronic kidney disease: a preventive strategy against acute kidney injury at the same time?
    Kidney Int. 2022;101:20-22.
    >> Share

    December 2021
  118. SUGIANTO RI, Memaran N, Schmidt BMW, Doyon A, et al
    Insights from the 4C-T Study suggest increased cardiovascular burden in girls with end stage kidney disease before and after kidney transplantation.
    Kidney Int. 2021 Dec 21. pii: S0085-2538(21)01163.
    >> Share

  119. FONSECA V, Kohzuma T, Galindo RJ, DeSouza C, et al
    KDIGO recommendations for the evaluation of glycemic control in advanced chronic kidney disease.
    Kidney Int. 2021 Dec 11. pii: S0085-2538(21)01088.
    >> Share

  120. NODA R, Kamano D, Abe T, Shinzawa S, et al
    Granuloma formation after peritoneal dialysis catheter-related infection by Mycobacterium chelonae.
    Kidney Int. 2021;100:1355.
    >> Share

  121. LOPEZ T, Banerjee D
    Management of fluid overload in hemodialysis patients.
    Kidney Int. 2021;100:1170-1173.
    >> Share

  122. EL-HUSSEINI A, Sobh M, Elshabrawy N, Abdalbary M, et al
    Antiresorptives in patients with chronic kidney disease with adynamic bone: Is absence of evidence of harm equal to no harm?
    Kidney Int. 2021;100:1341-1342.
    >> Share

  123. DRUEKE TB, Massy ZA
    Role of proteinuria in the anemia of chronic kidney disease.
    Kidney Int. 2021;100:1160-1162.
    >> Share

    November 2021
  124. ESPI M, Charmetant X, Barba T, Mathieu C, et al
    A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis.
    Kidney Int. 2021 Nov 29. pii: S0085-2538(21)01085.
    >> Share

  125. HU JR, Myint L, Levey AS, Coresh J, et al
    A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease.
    Kidney Int. 2021 Nov 26. pii: S0085-2538(21)01076.
    >> Share

  126. KAESLER N, Schreibing F, Speer T, Puente-Secades S, et al
    Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease.
    Kidney Int. 2021 Nov 10. pii: S0085-2538(21)01056.
    >> Share

  127. OGATA S, Akashi Y, Sakusabe T, Yoshizaki S, et al
    A multiple 24-hour urine collection study indicates that kidney function decline is related to urinary sodium and potassium excretion in patients with chronic kidney disease.
    Kidney Int. 2021 Nov 10. pii: S0085-2538(21)01057.
    >> Share

  128. JANKOWSKI V, Saritas T, Kjolby M, Hermann J, et al
    Carbamylated sortilin associates with cardiovascular calcification in patients with chronic kidney disease.
    Kidney Int. 2021 Nov 9. pii: S0085-2538(21)01034.
    >> Share

  129. DRUEKE TB
    Role of FGF23 in clinical outcomes of patients with chronic kidney disease.
    Kidney Int. 2021;100:993-994.
    >> Share

  130. KRONENBERG F
    Telomere length and chronic kidney disease: cause or consequence?
    Kidney Int. 2021;100:980-983.
    >> Share

  131. ROSEN RJ, Fernandez HE, Shirazian S, Moses AA, et al
    Ultrasound findings of calciphylaxis.
    Kidney Int. 2021;100:1144.
    >> Share

    October 2021
  132. TERKER AS, Ikizler TA
    Untangling the fibers of sarcopenia: activin A in chronic kidney disease-associated muscle wasting.
    Kidney Int. 2021 Oct 27. pii: S0085-2538(21)01022.
    >> Share

  133. DAVIDOVIC T, Schimpf J, Abbassi-Nik A, Stockinger R, et al
    Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost.
    Kidney Int. 2021 Oct 14. pii: S0085-2538(21)00942.
    >> Share

  134. PONTE B, Sadler MC, Olinger E, Vollenweider P, et al
    Mendelian randomization to assess causality between uromodulin, blood pressure and chronic kidney disease.
    Kidney Int. 2021 Oct 8. pii: S0085-2538(21)00922.
    >> Share

  135. STERVBO U, Blazquez-Navarro A, Blanco EV, Safi L, et al
    Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease.
    Kidney Int. 2021 Oct 4. pii: S0085-2538(21)00925.
    >> Share

    September 2021
  136. EIKELBOOM J, Floege J, Thadhani R, Weitz JI, et al
    Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target.
    Kidney Int. 2021 Sep 30. pii: S0085-2538(21)00870.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016